Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: OT, but related:

I agree with you that the CEO may calm a few shareholders with a well worded announcement. Those of us who came from the EDIG ranks know that song well. However, SIRI is losing $0.85 a share on a 6 billion dollar cap.

I don't believe PTSC's management owns warrants or options above the current pps, but I also don't believe it makes them any less agressive to create shareholder value. If we look at the larger picture, PTSC has gained 387% from where I first purchased (Thanks, Gil) at $0.16 less than two years ago. Not a bad return and I expect more good news in the future as a long term stock holder.

Of course, all comments based in the future are pure speculation, or wishful thinking, or just a plain ole WAG.

John

Share
New Message
Please login to post a reply